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Oligodendrocyte precursor cells (OPCs) are the progenitors of myelinating oligodendrocytes in brain development and repair.
Successful myelination depends on the control of adhesiveness during OPC migration and axon contact formation. The
decoration of cell surface proteins with the glycan polysialic acid (polySia) is a key regulatory element of OPC interactions
during development and under pathological conditions. By far the major protein carrier of polySia is the neural cell adhesion
molecule NCAM, but recently, polysialylation of the synaptic cell adhesion molecule SynCAM 1 has been detected in the
developing mouse brain. In mice, polySia-SynCAM 1 is associated with cells expressing NG2, a marker of a heterogeneous
precursor cell population, which is the primary source for oligodendrocytes in development and myelin repair but can also give
rise to astrocytes and possibly neurons. It is not yet clear if polySia-SynCAM 1 is expressed by OPCs and its occurrence in humans
is elusive. By generating uniform human embryonic stem cell-derived OPC cultures, we demonstrate that polySia is present on
human OPCs but down-regulated during differentiation into myelin basic protein-positive oligodendrocytes. PolySia on NCAM
resides on the isoforms NCAM-180 and NCAM-140, and SynCAM 1 is identified as a novel polySia acceptor in human OPCs.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Abbreviations: Endo, endosialidase; MBP, myelin basic protein;
NCAM, neural cell adhesion molecule; OPC, oligodendrocyte
precursor cells; PDGFRα, platelet-derived growth factor receptor
alpha; polySia, polysialic acid; polyST, polysialyltransferase;
SynCAM, synaptic cell adhesion molecule.
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Developmental myelination and myelin repair after demyelin-
ation are mediated by oligodendrocyte precursor cells (OPCs).
OPCs are characterized by markers such as PDGFRα and the
chondroitin sulfate proteoglycan NG2 (Dubois-Dalcq et al.,
2008; Franklin and Ffrench-Constant, 2008; Nishiyama et al.,
2009; Trotter et al., 2010). Differentiation protocols for theis is an open access article under the CC BY license
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OPCs have been described and successful myelination was
achieved by grafting of hESCd-OPCs into brain or spinal cord of
myelin-deficient shiverer mice (Nistor et al., 2005; Hu et al.,
2009a,b). Remyelination and improved functional recovery
after transplantation of hESCd-OPCs have also been demon-
strated in rat spinal cord injury (Keirstead et al., 2005; Sharp
et al., 2010) and recently, myelination by human induced
pluripotent stem cell (iPSC)-derived OPCs has been demon-
strated in themousemodel (Wang et al., 2013; Douvaras et al.,
2014). Thus, human stem cell-derived OPCs are on the way to
be used in replacement therapies for treating demyelinating
diseases (Goldman et al., 2012; Fox et al., 2014). Besides
environmental and axonal cues, the efficiency of myelination
is determined by the capacity of OPCs to migrate and to
interact with non-myelinated axons.
A regulatory factor of particularly these OPC properties is
the modification of the cell surface with the unique glycan
polysialic acid (polySia or PSA). The major carrier of polySia
is the neural cell adhesion molecule NCAM and its main
function is the modulation of cell surface interactions during
brain development and plasticity (Rutishauser, 2008;
Schnaar et al., 2014). PolySia on OPCs supports migration
towards demyelinated lesions (Wang et al., 1994;
Nait-Oumesmar et al., 1999, 2007; Zhang et al., 2004).
Accordingly, enhanced polysialylation improved the migra-
tion capacity of mouse ESC- and human iPSC-derived OPCs
(Glaser et al., 2007; Czepiel et al., 2014). In the course of
oligodendrocyte maturation and myelin formation, polySia
on OPCs is down-regulated and myelination is impairedwhen
the down-regulation of polySia is prevented (Fewou et al.,
2007). Moreover, polySia on axons inhibits myelination in
vitro (Charles et al., 2000) and chronically demyelinated
axons in multiple sclerosis lesions re-express polySia,
whereas shadow plaques with partial remyelination are
polySia-negative (Charles et al., 2002). Thus, polySia on
OPCs facilitates OPC recruitment and the presence of
polySia on OPCs and on axons may act as a negative
regulator of myelin formation.
PolySia synthesis is mediated by two independently
regulated polysialyltransferases (polySTs), ST8SIA2 and
ST8SIA4. Both enzymes show high acceptor specificity and
therefore polySia is restricted to only few carrier molecules
(Mühlenhoff et al., 2013). In addition to the major polySia
carrier NCAM, we recently described the ST8SIA2-mediated
polysialylation of a fraction of the synaptic cell adhesion
molecule SynCAM 1 within a subset of NG2 cells of the early
postnatal mouse brain (Galuska et al., 2010; Rollenhagen et
al., 2012). NG2 cells are able to communicate with neurons
via specialized neuron-NG2 cell synapses (Bergles et al.,
2000; Karadottir et al., 2005; Kukley et al., 2007; Etxeberria
et al., 2010). This axo-glial signaling may be involved in the
onset of myelination (De Biase et al., 2010; Kukley et al.,
2010). As SynCAM 1 is critical for assembly, organization and
maintenance of neuronal synapses (Biederer et al., 2002;
Stagi et al., 2010; Fogel et al., 2011) it may also contribute
to the formation of synapses between neurons and NG2 cells.
And because polySia attenuates adhesive interactions, it has
been proposed that polysialylation of SynCAM 1 modulates
the assembly or disassembly of neuron-NG2 cell synapses
(Galuska et al., 2010). However, many aspects of OPC
biology differ fundamentally between mice and humans (Simet al., 2009) and so far, the polySia modification of SynCAM 1
has only been shown in mice (Galuska et al., 2010;
Rollenhagen et al., 2012). Therefore, the present study
was designed to assess polySia acceptors in human OPCs
generated from ESCs.
Materials and methods
hESC culture and differentiation to OCPs
and oligodendrocytes
Human embryonic stem cells ES03 (hESCs, ES Cell Interna-
tional, National Stem Cell Bank Wisconsin) were main-
tained as described previously (Konze et al., 2014). The
protocol for OPC differentiation was adapted from Hu et al.
(2009a,b) (for details, see Supplementary material, extend-
ed methods).
Immunocytochemistry and microscopy
For immunocytochemistry hESCd-OPCs were cultivated in
24-well plates on glass coverslips coated with poly-L-
ornithine/laminin (Sigma-Aldrich). Fixed cells were perme-
abilized with 0.1% Triton X-100, stained and imaged as
described (Schiff et al., 2009). For details on antibodies,
specificity controls and image acquisition, see Supplemen-
tary material, extended methods.
RNA extraction, reverse transcription,
and quantitative real-time PCR
Total RNA from hESCd-OPCs was extracted using NucleoSpin
RNA II kit (Macherey-Nagel) and reverse transcribed as
described (Rollenhagen et al., 2012). Quantitative real-time
PCR was performed as described previously (Konze et al.,
2014). Relative mRNA levels of target genes were determined
by normalization to glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH; forward: 5′-ATGACATCAAGAAGGTGGTG-3′,
reverse: 5′-CATACCAGGAAATGAGCTTG-3′). Amplification of
ST8SIA2 and ST8SIA4 cDNA was performed using primers
specific for ST8SIA2 (forward: 5′-TGACGCCCACAGCTTCG-3′,
reverse: 5′-CATCCCGGGCATACTCCTG-3′) and ST8SIA4 (for-
ward: 5′-GACAAAAGAAATAGCAAGAACTGAGGA-3′, reverse:
5′-CCGACTCAAAGACAATTCACC-3′), generating products of
62 bp and 76 bp, respectively. PCR products were separated
on 6% non-denaturating polyacrylamide gels and visualized by
ethidium bromide.
Immunoprecipitation, SDS-PAGE andWestern blotting
hESCd-OPCs were lysed in 500 μl of 50 mM Tris/HCl, pH 8.0,
containing 150 mM NaCl, 5 mM EDTA, 2% (v/v) Triton
X-100, 0.5% (w/v) sodium deoxycholate, 200 U/ml aprotinin,
10 μg/ml leupetin and 2 mM phenylmethylsulfonylfluoride.
After centrifugation cell lysates were mixed with 100 μl of
mAb 735-conjugated tosylactivated magnetic dynabeads
(Invitrogen), incubated shaking for 2 h at 4 °C, washed and
eluted with Laemmli buffer. Immunoprecipitation (IP) of
SynCAM or depletion of NCAM from cell lysates was
performed accordingly, using Protein G Sepharose 4 Fast
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anti-NCAM mAb. For enzymatic removal of polySia, eluted
proteins were treated with 6 μg/ml endosialidase (Endo,
Stummeyer et al., 2005) for 30 min at 37 °C. SDS-PAGE (8%)
and Western blotting were carried out as described (Galuska
et al., 2010). For details, see Supplementary material,
extended methods.Figure 1 Efficient generation of polySia-positive OPCs from hESC
hESCs into OPCs and mature oligodendrocytes. Stem cell medium
(NDM), glial differentiation medium (GDM), neuroepithelial spher
methods. Micrographs show representative images of cells at the in
d132, immunofluorescence staining of myelin basic protein (MBP). (
Nuclear counterstain with DAPI (blue). (D) Evaluation of PDGFRα an
cultures at d98 expressed as % of all DAPI- or polySia-positive cells
(E) Co-staining of polySia with OLIG2 and PDGFRα at d98. (E′) Mi
perinuclear polySia immunoreactivity (arrow) of the cell depicted
polySia-positive cells. Scale bars, 50 μM (A) or 20 μM (B, C, E–H). (I)
hESCd-OPC cultures with primers specific for ST8SIA2 and ST8SIA4.Results and discussion
hESCd-OPCs are positive for polySia,
NCAM and SynCAM 1
The differentiation procedure started from hESCs cultured
on γ-irradiated human fibroblasts as described previouslys. (A) Schematic procedure for the directed differentiation of
(SCM), hESC medium (hESCM), neural differentiation medium
es (NES). For details see Supplementary material, extended
dicated days of differentiation (d). d0–d98, bright field images,
B, C) Expression of the OPC markers OLIG2 and PDGFRα at d98.
d OLIG2 double-positive or double-negative cells in hESCd-OPC
, as indicated (mean ± SEM from n = 3 independent cultures).
crograph acquired with short exposure time highlights strong
in (E). (F–H) Staining for NCAM and SynCAM 1 in NG2- and
Bands obtained by reverse transcription PCR performed from d98
342 S. Werneburg et al.(Konze et al., 2014) and is depicted in Fig. 1A. After 98 days
of differentiation (d98) this procedure reproducibly generat-
ed cultures containing N90% hESC-derived bi- and multipolar
cells positive for OLIG2, PDGFRα and NG2 (Fig. 1B–F).
Although none of these markers on its own is exclusive to the
oligodendrocyte lineage (Nishiyama et al., 2009; Trotter et
al., 2010), the combined expression of these markers
provides substantial evidence that the differentiation pro-
cedure gives rise to OPCs. To corroborate the largely uni-
form composition, d98 OPC cultures were screened for
the presence of astrocytic or neuronally committed cells
using GFAP-, Pax6-, ß-III-tubulin- and doublecortin (DCX)-
specific antibodies. In contrast to neurally induced hESC-
derived cultures with numerous Pax6-, ß-III-tubulin- and
DCX-positive neural precursor cells (NPCs; see Supplemen-
tary material, Fig. S1), none of these markers could be
detected in d98 OPC cultures. Virtually all cells identified
as OPCs showed polySia immunoreactivity, while the few
PDGFRα- and OLIG2-negative cells were essentially devoid
of polySia signals (Fig. 1D–F). This is consistent with previous
reports showing polySia on murine OPCs and human sub-
ventricular zone-derived glial progenitors in vivo (Nait-
Oumesmar et al., 1995, 1999, 2007; Picard-Riera et al.,
2002) and with a recent study demonstrating the presence of
polySia in human iPSC-derived OPCs (Czepiel et al., 2014).
PolySia was distributed over the whole cell body, including
protrusions (Fig. 1E–H), but micrographs acquired with short
exposure time indicated a particularly strong perinuclear
signal (Fig. 1E′, arrow). In addition to NCAM, which so far
is the only known polySia acceptor in the human brain (Cox
et al., 2009), all hESCd-OPCs expressed SynCAM 1 together
with NG2 and polySia (Fig. 1F–H). Analysis by RT-PCR in-
dicated mRNA expression of the two mammalian polySTs
ST8SIA2 and ST8SIA4 (Fig. 1I). PolySia on NCAM can be
produced by both enzymes, whereas murine SynCAM 1 is
polysialylated exclusively by ST8SIA2 (Rollenhagen et al.,
2012). Therefore, the presence of both polyST transcriptsFigure 2 PolySia is attached to NCAM and SynCAM 1 in hESCd-OPC
with mAb 735-conjugated beads. Prior to SDS-PAGE, one part of eac
developed with polySia-specific mAb 735, and, after stripping, with
in the presence of polySia, the binding of mAb 123C3 to its epitope
reduced (Hildebrandt et al., 1998). (B) IP of polysialylated proteins
123C3. Western blot with mAb 735, and, after stripping, with SynCAM
hESCd-OPC lysates with SynCAM-specific pAb. WB and Endo treatm
Molecular masses (kDa) of standard proteins are indicated.indicates that hESCd-OPCs have the capacity to polysialylate
NCAM and SynCAM 1.PolySia in hESCd-OPCs is attached to NCAM
and SynCAM 1
To identify polySia acceptors in hESCd-OPCs, total
polysialylated proteins were isolated by immunoprecipita-
tion (IP) with the polySia-specific mAb 735. Immunoblotting
demonstrated broad signals characteristic for polysialylated
proteins, ranging from ~95 to 220 kDa (Fig. 2A) (Mühlenhoff
et al., 1996; Galuska et al., 2010; Rollenhagen et al., 2012,
2013). These signals were completely abolished by incuba-
tion of samples with Endo, which degrades polySia with high
specificity (Stummeyer et al., 2005). Western blot analysis
with NCAM-specific antibodies demonstrated that the strong
polySia signal above ~140 kDa represents polySia-NCAM.
After Endo treatment the polySia-NCAM smear resolved into
two sharp bands corresponding to NCAM-140 and NCAM-180.
This is the first evidence that human OPCs carry polySia on
the same NCAM isoforms that are known to be polysialylated
during postnatal development in mouse brain and human
cortex (Oltmann-Norden et al., 2008; Cox et al., 2009).
NCAM depletion from hESCd-OPC lysates resulted in a clear
reduction of the polySia signal above ~140 kDa, whereas the
polySia signal centered around 110 kDa was not affected
(Fig. 2B, left). Immunodetection with SynCAM-specific anti-
body on the same membrane resulted in bands corresponding
to the lower polySia signal, which broadened towards lower
apparent molecular masses upon polySia removal by Endo
treatment (Fig. 2B, right). Reversely, IP with SynCAM-specific
antibody resulted in polySia and SynCAM signals centered
around 110 kDa (Fig. 2C). In addition, non-polysialylated
SynCAM was detected in the lower molecular weight range
between ~60 and 75 kDa. These signals correspond to the
extensively glycosylated, but not polysialylated SynCAMs. (A) IP of total polysialylated proteins from hESCd-OPC lysates
h sample was treated with endosialidase (Endo +). Western blot
NCAM-specific mAb 123C3, as indicated. Due to steric hindrance
in the extracellular domain of polysialylated NCAM is strongly
from hESCd-OPC lysates after depletion of NCAM by IP with mAb
-specific pAb. Endo treatment as indicated [see (A)]. (C) IP from
ent as in (B). Asterisk marks polySia-negative SynCAM species.
343Polysialic acid in human ES cell-derived OPCsspecies detected in rat and mouse brain samples (Biederer
et al., 2002; Rollenhagen et al., 2012). The concordant polySia
and SynCAM signals obtained by Western blot as well as theFigure 3 Polysialylation of NCAM and SynCAM 1 is down-regulate
(A–C) Cells stained for myelin basic protein (MBP), NG2 and polySia i
(D) PolySia IP of d132 cultures and Western blot analysis of un
SynCAM-specific antibodies. (E) Western blot analysis of SynCAM in th
hESCd cultures. Molecular masses (kDa) of standard proteins are i
hESCd-cultures at d98 and d132. Values represent mean ± SEM from 3
t-test.minor shift caused by the specific removal of polySia are in
perfect agreement with the features described for
polySia-SynCAM 1 isolated from mouse brain (Galuska et al.,d during differentiation of OPCs into mature oligodendrocytes.
n hESCd-cultures at d98 and d132 as indicated. Scale bars, 20 μM.
treated or Endo-treated samples with polySia-, NCAM-, and
e range of ~110 kDa in untreated or Endo-treated lysates of d132
ndicated. (F) Relative mRNA level for ST8SIA2 and ST8SIA4 in
independent replicates. *, significant differences with P b 0.05,
344 S. Werneburg et al.2010; Rollenhagen et al., 2012). Together, these data prove
that human ESC-derived OPCs express polysialylated SynCAM 1
and provide the first evidence that SynCAM 1 is an acceptor for
posttranslational modification with polySia in humans.PolySia is down-regulated during
oligodendrocyte maturation
PolySia expression of rodent OPCs is down-regulated during
differentiation into mature myelinating oligodendrocytes
(Trotter et al., 1989; Bartsch et al., 1990; Nait-Oumesmar
et al., 1995; Wang et al., 1994). We therefore analyzed
changes of polySia expression between d98 hESCd-OPCs and
cultures differentiated until d132. At d98, almost all of the cells
expressed OPC markers and had only few processes (see
Fig. 1). In addition, none of the cells were immunopositive for
MBP, which was assessed by mAb SMI-99, a marker of mature
oligodendrocytes in rodents and humans (Sternberger et al.,
1978; Back et al., 2001) (Fig. 3A). At d132 most of the cells had
the appearance of mature oligodendrocytes with multiple
branched processes and were positive for MBP, but not NG2
or polySia (Fig. 3B). Only some cells (~5%) remained positive
for NG2 and polySia (Fig. 3C). In addition, a few scarce
GFAP-immunoreactive cells (b1% of all DAPI+ cells), but no
neuronal, Pax6-, ß-III-tubulin- or DCX-positive cells were
detected (see Supplementary material, Fig. S1). Despite the
relatively high proportion of cells that acquired MBP expres-
sion in d132 cultures, cellular heterogeneity is an inherent
confounding feature of pluripotent stem cell differentiation
systems. As broadly discussed by, e.g., Solozobova et al.
(2012) it is hardly possible to maintain cell type identity by
in vitro differentiation approaches, like the one employed in
the current study. Thus, for biomedical applications possible
deviations from the oligodendrocytic specification achieved
by the current protocol should be critically monitored.
The analysis of polySia after IP from d132 cultures revealed
a depletion of polySia-SynCAM 1 below the detection level,
and a strong reduction of polySia-NCAM immunoreactivity
(Fig. 3D). Western blot analysis of SynCAM in whole cell lysates
of d132 cultures demonstrated that the broad SynCAM signal in
the range of 110 kDa is still present, implicating a specific
down-regulation of the polysialylated fraction of SynCAM 1
upon further differentiation (Fig. 3E). As polySia expression
depends mainly on the balance between synthesis and
degradation of polysialylated structures (Hildebrandt et al.,
2010) we sought to assess if the down-regulation of polySia
during oligodendrocyte maturation is a consequence of
reduced polyST expression. As shown in Fig. 3F, a significant
reduction of the ST8SIA2 mRNA level and a trend towards a
reduction of ST8SIA4 was detected, suggesting regulation at
the transcriptional level. In contrast to NCAM, polysialylation
of SynCAM 1 is exclusively mediated by ST8SIA2 (Rollenhagen
et al., 2012). Hence, the stronger reduction of ST8SIA2 mRNA
is consistent with the more pronounced decrease of
polySia-SynCAM 1. It will be of interest to further explore the
mechanisms behind this transcriptional down-regulation, e.g.,
if it is mediated by miRNAs. So far, however, little is known
about miRNA regulation of polySTs. As judged by the total
number of predicted miRNA binding sites within the 3′UTR,
both polySTs show a relatively high level of miRNA regulation
(Kasper et al., 2014) and ST8SIA4 is a predicted target ofmiR-30b, which is abundant in primary human neuronal and
glial cells and under-expressed in Parkinson's disease patients
(Martins et al., 2011).
In summary, the current study demonstrates that human
ESC-derived OPCs express polySia on the NCAM isoforms
NCAM-180 and NCAM-140, and identifies SynCAM 1 as a novel
polySia acceptor in human OPCs. So far, polySia has not been
detected on OPCs of the human CNS, but on demyelinated
axons and astrocytic cells in the vicinity of polySia-negative
remyelinated axons of chronic multiple sclerosis lesions
(Charles et al., 2002). Possibly, polysialylated OPCs were not
found because OPCs are reduced and/or in a quiescent state in
chronic multiple sclerosis lesions, which may prevent the
generation of newmyelin-forming oligodendrocytes (Wolswijk,
2002). Based on the broad evidence for a crucial role of polySia
in OPC performance, the current finding that polySia-positive
human OPCs readily produce polySia-negative, MBP-positive
oligodendrocytes raises the expectation that polySia-positive
OPCs provide a source for actively remyelinating cells in
transplantation approaches for treating demyelinating dis-
eases. Furthermore, considering the role of SynCAM 1 in the
coordination of synaptic adhesion, the regulation of polySia-
SynCAM 1 during oligodendrocyte maturation holds the
potential to modulate synaptic contacts between NG2 cells/
OPCs and axons and may be important for the onset of
myelination. Since the polysialylation of SynCAM 1 depends
exclusively on ST8SIA2 (Rollenhagen et al., 2012) the manip-
ulation of ST8SIA2 activity should be considered as a strategy
for guiding myelination from human stem cell-derived OPCs
in biomedical applications. Indeed, ST8SIA2 may be an
interesting druggable target to control polySia expression.
Although further studies are needed to develop reagents such
as specific small molecule inhibitors of polyST activity (Al
Saraireh et al., 2013) or vectors for ST8SIA2 RNA interference
(Brocco and Frasch, 2006), the time-controlled inhibition of
ST8SIA2 after grafting of OPCs may offer a valuable tool in
novel therapeutic approaches for, e.g., multiple sclerosis or
spinal cord injury.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2015.03.001.
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